Your browser doesn't support javascript.
loading
Antimicrobial resistance patterns of Acinetobacter spp. of animal origin reveal high rate of multidrug resistance.
Maboni, Grazieli; Seguel, Mauricio; Lorton, Ana; Sanchez, Susan.
Afiliação
  • Maboni G; Athens Veterinary Diagnostic Laboratory, University of Georgia, Athens, GA, USA. Electronic address: grazieli.maboni@gmail.com.
  • Seguel M; Odum School of Ecology, University of Georgia, Athens, GA, USA.
  • Lorton A; Athens Veterinary Diagnostic Laboratory, University of Georgia, Athens, GA, USA.
  • Sanchez S; Athens Veterinary Diagnostic Laboratory, University of Georgia, Athens, GA, USA; Department of Infectious Diseases, College of Veterinary Medicine, The University of Georgia, Athens, GA, USA.
Vet Microbiol ; 245: 108702, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32456823
ABSTRACT
Antimicrobial resistance has been declared by the World Health Organization as one of the biggest threats to public health and Acinetobacter baumannii is a notable example. A. baumannii is an important human nosocomial pathogen, being along with other multidrug resistant (MDR) bacteria, one of the biggest public health concerns worldwide. In Veterinary Medicine, resistance patterns of Acinetobacter species other than A. baumanii are unclear, and the scarce information available is limited and fragmented. We applied a statistical modeling approach to investigate the occurrence, clinical relevance and antimicrobial resistant phenotypes of Acinetobacter spp. originated from animals. Seven Acinetobacter species were identified in clinical specimens of more than 15 different domestic, zoo and exotic animal species. We found a high rate of MDR A. baumannii of canine origin with some of these isolates originating from serious systemic or wound infections, which highlights their potential pathogenic profile and spread in the human environment. Data also revealed different antimicrobial resistance patterns of animal-origin Acinetobacter species, emphasizing the necessity to implement specific antimicrobial susceptibility recommendations for animal isolates as there are no such clinical breakpoints currently in place. This study provides substantial advancing in our understanding of Acinetobacter spp. in animal clinical specimens, and highlights the role of animals in the dynamics of multidrug resistance in bacteria. The data presented here is a valuable source of information for further establishment of clinical breakpoints for susceptibility testing of animal-associated Acinetobacter isolates.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Acinetobacter / Farmacorresistência Bacteriana Múltipla / Acinetobacter baumannii / Antibacterianos Tipo de estudo: Guideline Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Acinetobacter / Farmacorresistência Bacteriana Múltipla / Acinetobacter baumannii / Antibacterianos Tipo de estudo: Guideline Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article